IP Library › Granted Patent US 9,771,381
Granted Patent B2
US 9,771,381 · App. 14/153,752 · Granted Sep 26, 2017

Derivatives of 1-amino-2-cyclobutylethylboronic acid

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,771,381
App. No.
14/153,752
Granted
Sep 26, 2017
Kind
B2
Abstract

The present invention provides novel compounds useful as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.

Claims (4)

1. A compound selected from

or a pharmaceutically acceptable salt or boronic acid anhydride thereof.

2. The compound of claim 1 , which is

or a pharmaceutically acceptable salt or boronic acid anhydride thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2021
From: MILLENNIUM PHARMACEUTICALS, INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 056729/0503 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2014
From: FLEMING, PAUL E.; LI, JING
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 031957/0612 →